IP Library Assignment 060141/0204
Patent Assignment
Reel/Frame 060141/0204

Assignment of Assignor's Interest

Recorded: 2022-06-08 Pages: 5
Assignor
RVX THERAPEUTICS INC.
Executed: 2014-05-01
Assignee
ZENITH EPIGENETICS CORP.
300, 4820 RICHARD ROAD, SW, CALGARY, ALBERTA, T3E 6L1, CANADA
Covered Property (1)
Novel Bicyclic Bromodomain Inhibitors
Application: 16/940,785 →
Publication: US 2021/0177855
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 8, 2022
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: RVX THERAPEUTICS INC.
Reel/Frame 060141/0182 →
Assignment of Assignor's Interest Jun 8, 2022
From: QUINN, JOHN FREDERICK; WAGNER, GREGORY STEVEN; DUFFY, BRYAN CORDELL; LIU, SHUANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 060314/0739 →
Change of Name Jun 8, 2022
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 060314/0745 →
Assignment of Assignor's Interest Jun 8, 2022
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 060314/0756 →